Literature DB >> 1934550

Chronic otitis media and ankylosing spondylitis: an HLA association?

A E Camilleri1, I R Swan, R Sturrock.   

Abstract

A prospective study was undertaken to investigate an apparent correlation between ankylosing spondylitis (AS) and the incidence of otological conditions. 42 consecutive patients attending the ankylosing spondylitis clinic were examined otoscopically and had audiometric assessment. 19% of the patients (8/42) had active or inactive chronic otitis media. The prevalence of chronic otitis media in this group was significantly greater (P less than 0.01) than a stratified sample of the general population from the Medical Research Council Institute of Hearing Research National Study of Hearing, controlled for age, sex and socio-economic group, where the expected incidence was 5%. A hypothetical explanation for the association is given and the need for HLA studies into chronic otitis media is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934550     DOI: 10.1111/j.1365-2273.1991.tb00949.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  3 in total

1.  Chronic otitis media: a new extra-articular manifestation in ankylosing spondylitis?

Authors:  A E Camilleri; I R Swan; E Murphy; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

2.  High-frequency sensorineural hearing loss in patients with ankylosing spondylitis: is it an extrarticuler feature of disease?

Authors:  Mehmet Adam; Alper Nabi Erkan; Didem Arslan; Berrin Leblebici; Levent Ozlüoğlu; M Nafiz Akman
Journal:  Rheumatol Int       Date:  2007-09-26       Impact factor: 2.631

3.  Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds.

Authors:  Nazim Bozan; Mahmut Alpaycı; Mehmet Aslan; Hakan Cankaya; Ahmet Faruk Kıroglu; Mahfuz Turan; Abdurrahman Ayral; Emre Senkoy; Server Ilter
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-31       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.